Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.

Santo Colosimo Federico Ravaioli Maria Letizia Petroni Lucia Brodosi Francesca Marchignoli Francesca A Barbanti Anna Simona Sasdelli Giulio Marchesini Loris Pironi

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

Glucagon-like peptide-1 receptor agonists and SGLT-2Is improve biomarkers of steatosis and fibrosis, in keeping with beneficial effects on liver disease progression, and should be considered the treatment of choice in T2D.

Keyphrases

data analysis
insulin resistance
type diabetes
high fat diet
high fat diet induced
cardiovascular disease
glycemic control
liver fibrosis
skeletal muscle
weight loss
replacement therapy
smoking cessation